PETS official logo PETS
PETS 1-star rating from Upturn Advisory
PetMed Express Inc (PETS) company logo

PetMed Express Inc (PETS)

PetMed Express Inc (PETS) 1-star rating from Upturn Advisory
$3.32
Last Close (24-hour delay)
Profit since last BUY-10.27%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 16 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/09/2026: PETS (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

2 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $2.75

1 Year Target Price $2.75

Analysts Price Target For last 52 week
$2.75 Target price
52w Low $1.57
Current$3.32
52w High $5.58

Analysis of Past Performance

Type Stock
Historic Profit -1.82%
Avg. Invested days 34
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 01/09/2026

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 70.95M USD
Price to earnings Ratio -
1Y Target Price 2.75
Price to earnings Ratio -
1Y Target Price 2.75
Volume (30-day avg) 2
Beta 0.66
52 Weeks Range 1.57 - 5.58
Updated Date 01/9/2026
52 Weeks Range 1.57 - 5.58
Updated Date 01/9/2026
Dividends yield (FY) -
Basic EPS (TTM) -2.65

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -27.75%
Operating Margin (TTM) -16.13%

Management Effectiveness

Return on Assets (TTM) -14.11%
Return on Equity (TTM) -78.89%

Valuation

Trailing PE -
Forward PE 17.92
Enterprise Value 35625809
Price to Sales(TTM) 0.36
Enterprise Value 35625809
Price to Sales(TTM) 0.36
Enterprise Value to Revenue 0.18
Enterprise Value to EBITDA 0.63
Shares Outstanding 21369521
Shares Floating 13982600
Shares Outstanding 21369521
Shares Floating 13982600
Percent Insiders 31.2
Percent Institutions 35.29

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

PetMed Express Inc

PetMed Express Inc(PETS) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

PetMed Express Inc. was founded in 1996 as an independent online pet pharmacy. It aimed to provide a convenient and affordable way for pet owners to purchase prescription and non-prescription pet medications and supplies. Over the years, it has established itself as a significant player in the burgeoning online pet health market.

Company business area logo Core Business Areas

  • Pet Medications: The primary business of PetMed Express is the sale of prescription medications for pets, including flea and tick preventatives, heartworm medications, antibiotics, and pain relievers. They operate as a licensed pharmacy and require veterinary prescriptions for these items.
  • Pet Supplies: Beyond medications, PetMed Express also offers a range of pet supplies such as food, treats, vitamins, supplements, grooming products, and accessories.
  • Customer Service and Convenience: A key aspect of their offering is the convenience of home delivery and auto-ship options for recurring medication needs.

leadership logo Leadership and Structure

PetMed Express Inc. is a publicly traded company. As of recent filings, the company's leadership includes a CEO, CFO, and a Board of Directors. The organizational structure is typical for an e-commerce and pharmacy business, encompassing operations, marketing, customer service, and IT departments.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Product Name 1: Flea and Tick Preventatives: This category includes popular brands and generic options for protecting pets from common parasites. Competitors include major veterinary pharmaceutical companies and other online pet pharmacies. Market share data for specific product categories is not publicly disclosed in detail, but this is a significant revenue driver.
  • Product Name 2: Heartworm Medications: Essential for pet health in many regions, these medications are a core offering. Competitors are similar to flea and tick preventatives, with major pharmaceutical companies dominating the branded product space.
  • Product Name 3: Pain Management Medications: Prescription pain relievers for various pet conditions contribute to sales. This segment also faces competition from veterinary clinics and other online pharmacies.

Market Dynamics

industry overview logo Industry Overview

The pet industry, particularly the pet health and wellness sector, has shown consistent growth. Factors driving this growth include increased pet ownership, humanization of pets (treating pets as family members), and a willingness among owners to spend on their pets' health and well-being. The online retail segment for pet products is also expanding due to convenience and competitive pricing.

Positioning

PetMed Express Inc. is positioned as a leading online retailer of prescription pet medications and supplies in the United States. Its competitive advantages include a long-standing reputation, established customer base, and a focus on prescription fulfillment. However, it faces increasing competition from brick-and-mortar veterinary clinics, large online retailers with pet sections, and emerging direct-to-consumer pet health brands.

Total Addressable Market (TAM)

The total addressable market for pet medications and supplies in the U.S. is substantial and continues to grow, estimated to be tens of billions of dollars annually. PetMed Express Inc. holds a notable share of the online segment of this market, but the overall TAM also includes sales from veterinary clinics, which represent a significant portion of prescription medication sales.

Upturn SWOT Analysis

Strengths

  • Established brand recognition and customer loyalty.
  • Extensive experience in online pet pharmacy operations.
  • Strong relationships with pharmaceutical suppliers.
  • Convenient home delivery and auto-ship services.
  • Broad product catalog including both prescription and OTC items.

Weaknesses

  • Reliance on veterinary prescriptions, which can be a bottleneck.
  • Increasing competition from veterinary clinics offering in-house pharmacies and direct sales.
  • Potential for price competition from larger online retailers.
  • Limited diversification beyond core pet medication and supply sales.
  • Perceived by some as less personal than a local vet's office.

Opportunities

  • Expansion of private label products.
  • Partnerships with veterinary practices or pet insurance providers.
  • Growth in the telehealth for pets market, which could drive prescription demand.
  • Increasing demand for specialized pet diets and supplements.
  • Further penetration into the non-prescription pet supply market.

Threats

  • Regulatory changes affecting online pharmacies.
  • Intensifying competition from both online and offline players.
  • Potential for supply chain disruptions.
  • Economic downturns affecting consumer discretionary spending on pets.
  • Cybersecurity risks inherent in online retail and pharmacy operations.

Competitors and Market Share

Key competitor logo Key Competitors

  • Chewy Inc. (CHWY)
  • Amazon.com Inc. (AMZN)
  • Veterinary Clinics (various local and national networks)

Competitive Landscape

PetMed Express's advantage lies in its specialized focus on pet medications and its established pharmacy operations. However, it faces significant disadvantages in terms of scale and breadth of offerings compared to giants like Amazon and Chewy, which also offer a wider range of pet products and have massive customer bases. Veterinary clinics remain a formidable competitor for prescription sales due to the direct relationship and trust with pet owners.

Growth Trajectory and Initiatives

Historical Growth: Historically, PetMed Express experienced significant growth as an early mover in the online pet pharmacy space. This growth was fueled by the convenience factor and competitive pricing. However, recent years have seen challenges to this growth trajectory due to market saturation and increased competition.

Future Projections: Future projections are often influenced by analyst estimates, which would consider the company's ability to adapt to evolving market dynamics, manage competition, and innovate its product and service offerings. Analysts have shown mixed outlooks, with some projecting modest declines and others stable performance.

Recent Initiatives: Recent initiatives have likely focused on enhancing the customer experience, potentially exploring new product lines, improving marketing strategies, and optimizing operational efficiencies to counter competitive pressures. There has also been a focus on efforts to stabilize and potentially grow the business.

Summary

PetMed Express Inc. is a veteran online pet pharmacy facing intense competition in a growing market. Its strengths lie in its established brand and pharmacy expertise, while its weaknesses include limited scale and a reliance on prescriptions. Opportunities exist in product diversification and strategic partnerships, but threats from larger competitors and regulatory shifts require careful navigation. The company needs to innovate and adapt its strategy to regain growth momentum and solidify its market position.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company Investor Relations Filings (e.g., SEC filings)
  • Financial Data Providers (e.g., Refinitiv, Bloomberg)
  • Industry Research Reports
  • Company Website

Disclaimers:

This analysis is based on publicly available information and is intended for informational purposes only. It does not constitute investment advice. Financial data and market share figures are estimates and can change. Investors should conduct their own due diligence before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About PetMed Express Inc

Exchange NASDAQ
Headquaters Delray Beach, FL, United States
IPO Launch date 1999-04-26
Executive Chairman of the Board, Interim CEO & President Ms. Leslie C. G. Campbell
Sector Healthcare
Industry Pharmaceutical Retailers
Full time employees 173
Full time employees 173

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.